Kyowa Kirin Research Grants
Kyowa Kirin Research Grants fund independent research on rare hematologic cancers and bone/mineral diseases, with a focus on innovative therapies and advancing patient outcomes.
Browse similar grants
Funder: Kyowa Kirin
Due Dates: Rolling (Submit at least 90 days before project start date) | July 31, 2026 (CME CTCL RFP) | August 20, 2020 (CTCL Disparities RFP, closed)
Funding Amounts: Varies by project; typical range $5,000–$100,000 (CME RFP); up to $35,000 (CTCL disparities RFP, closed); budgets must be reasonable and cost-effective.
Summary: Supports independent research advancing knowledge in rare hematologic cancers, bone/mineral diseases, and related therapies, with a focus on innovative treatments and patient outcomes.
Key Information: Not open to individual healthcare professionals or physician practices; must apply as an organization or eligible entity.
Description
Kyowa Kirin Research Grants support independent research initiatives that enhance scientific and medical understanding in rare hematologic cancers, hematologic diseases, and bone and mineral disorders. Funding is available for data collection, registry creation or maintenance, investigator-initiated studies, and publication of new research, especially those aligned with advanced therapeutic antibodies and hematopoietic stem cell gene therapies. The grants are intended to drive impactful, independent research that improves patient outcomes, supports high-impact data generation, and advances disease knowledge for the benefit of patients, families, and the broader healthcare community.
